Introduction In the domain of oncology, immunotherapy has emerged as a pioneering methodology, harnessing the body's immune system to combat malignant tumors. There are many immunotherapeutic approaches, but Chimeric Antigen Rece..
Introduction Cytokine Release Syndrome (CRS) is an immune system overreaction triggered by therapies like immunotherapy or CAR-T cell treatment. It prompts an influx of cytokines, causing symptoms ranging from fever to potentiall..
Patients undergoing outpatient CAR T-cell therapy for cancer must be cared for by a multidisciplinary team that includes nurse coordinators, according to a poster presented at the 49th Annual Oncology Nursing Society Conference. ..
Introduction CAR T cell therapy, an innovative form of immunotherapy, has demonstrated exceptional efficacy in the treatment of specific tumors by leveraging the potency of a patient's own immune system. Recently, scientists have..
Feb 2024: China's pioneering efforts in creating breakthrough cancer therapeutics have gained traction with the introduction of chimeric antigen receptor (CAR)-engineered T-cell (CAR T) therapy for multiple myeloma, a devastatin..
Discover the magic of CAR-T treatment! Read our blog on patient selection for CAR T therapy. Are you the ideal candidate for this innovative cancer treatment? Find out and begin your personalized journey to cancer recovery. He..
The revolutionary CAR T Cell Therapy is changing the scenario of how we deal with cancer, making it more personal and powerful. This latest therapy uses a patient's own immune cells and genetically modifies them to target and des..
Mayo de 2023: la terapia de células T con receptor de antígeno quimérico (CAR) es un desarrollo innovador en el campo de la terapia individualizada contra el cáncer. Las propias células T del paciente se modifican genéticamente durante el proceso de fabricación para expresar una...
Marzo de 2023: El primer capítulo de las memorias de Sam Neill sería un tremendo susto para alguien que no tenía conocimiento previo del mismo. Comienza bastante divertido: una gran historia sobre su hija Elena siendo interrogada sobre el trabajo de su padre..
Marzo de 2023: Breve resumen: El propósito de este ensayo clínico es determinar si la terapia de células T con receptor de antígeno MESO se puede utilizar para tratar el cáncer de ovario epitelial que ha regresado o ha dejado de responder a otros.